U. Albrecht u. a.: Efficacy and safety of a herbal medicinal product containing myrrh, chamomile and coffee charcoal for the treatment of gastrointestinal disorders: a non-interventional study. In: BMJ Open Gastro. 1:e000015, 2014, doi:10.1136/bmjgast-2014-000015 (bmj.com [PDF]).
Zeenat Gaibee, Neil Warner, Katlynn Bugda Gwilt, Wenjuan Li, Rei Guan, Michael Yourshaw, Ryder Whittaker Hawkins, Aleixo M. Muise et al.: The Genetic Architecture of Congenital Diarrhea and Enteropathy. New England Journal of Medicine 2025, Band 392, Ausgabe 13 vom 3. April 2025, Seiten 1297–1309, DOI: 10.1056/NEJMoa2405333
Gerhard J Molderings, Britta Haenisch, Stefan Brettner et al.: Pharmacological treatment options for mast cell activation disease. In: Naunyn Schmiedebergs Arch Pharmacol. Band389, Nr.7, 30. April 2016, S.671-94., doi:10.1007/s00210-016-1247-1, PMID 27132234, PMC 4903110 (freier Volltext).
Lawrence B. Afrin, Sally Self, Jeremiah Menk, John Lazarchick: Characterization of Mast Cell Activation Syndrome. In: The American Journal of the Medical Science. Band353, Nr.3, 16. Dezember 2016, S.207–215, doi:10.1016/j.amjms.2016.12.013, PMID 28262205, PMC 5341697 (freier Volltext).
Peter Valent, Cem Akin, Boguslaw Nedoszytko et al.: Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine. In: International Journal of Molecular Sciences. Band21, Nr.23, 27. November 2020, S.3f., doi:10.3390/ijms21239030, PMID 33261124, PMC 7731385 (freier Volltext).
Sibylle Koletzko, Stephanie Osterrieder: Akute infektiöse Durchfallerkrankung im Kindesalter. In: Deutsches Ärzteblatt International. Band 106, Nr. 33, 2009, S. 539–547. doi:10.3238/arztebl.2009.0539
V. Tsimihodimos, V. Kakaidi, M. Elisaf: Cola-induced hypokalaemia: pathophysiological mechanisms and clinical implications. In: International Journal of Clinical Practice. Band 63, Nr. 6, 2009, S. 900–902. doi:10.1111/j.1742-1241.2009.02051.x
U. Albrecht u. a.: Efficacy and safety of a herbal medicinal product containing myrrh, chamomile and coffee charcoal for the treatment of gastrointestinal disorders: a non-interventional study. In: BMJ Open Gastro. 1:e000015, 2014, doi:10.1136/bmjgast-2014-000015 (bmj.com [PDF]).
C. Vissiennon u. a.: Antispasmodic Effects of Myrrh due to Calcium Antagonistic Effects in Inflamed Rat Small Intestinal Preparations. In: Planta Med. Band 81, Nr. 2, Jan 2015, S. 116–122, doi:10.1055/s-0034-1383391.
Gerhard J Molderings, Britta Haenisch, Stefan Brettner et al.: Pharmacological treatment options for mast cell activation disease. In: Naunyn Schmiedebergs Arch Pharmacol. Band389, Nr.7, 30. April 2016, S.671-94., doi:10.1007/s00210-016-1247-1, PMID 27132234, PMC 4903110 (freier Volltext).
Lawrence B. Afrin, Sally Self, Jeremiah Menk, John Lazarchick: Characterization of Mast Cell Activation Syndrome. In: The American Journal of the Medical Science. Band353, Nr.3, 16. Dezember 2016, S.207–215, doi:10.1016/j.amjms.2016.12.013, PMID 28262205, PMC 5341697 (freier Volltext).
Peter Valent, Cem Akin, Boguslaw Nedoszytko et al.: Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine. In: International Journal of Molecular Sciences. Band21, Nr.23, 27. November 2020, S.3f., doi:10.3390/ijms21239030, PMID 33261124, PMC 7731385 (freier Volltext).